Health Alerts

The Centers for Disease Control and Prevention (CDC) are suggesting that susceptible US citizens over 18 years of age should consider the chikungunya vaccine if they are travelling to a country or territory experiencing an outbreak of the disease and likely to have moderate exposure to mosquitoes, or for stays longer than six months. The vaccine has been approved for use in the USA since November 2023. Read more